Beckman assimilates Coulter in quarterly results
This article was originally published in Clinica
Executive Summary
In the first full quarter following the acquisition of Coulter by Beckman Instruments, the combined company Beckman Coulter had sales of $399 million. This represents a 72% increase on Beckman's first quarter in 1997. As a private company, Coulter only revealed annual figures of $700 million for the full year in 1996. Currency effects lowered sales by some 5%. The figures include only two months of Coulter's international sales to synchronise the two companies' accounting systems.
You may also be interested in...
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.